clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Hyperemesis Gravidarum D006939 2 associated lipids
Empyema, Pleural D016724 2 associated lipids
Mastoiditis D008417 2 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Scrub Typhus D012612 3 associated lipids
Tuberculosis, Avian D014379 2 associated lipids
Typhoid Fever D014435 2 associated lipids
Central Nervous System Protozoal Infections D020808 3 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Caliskan R et al. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. Rev. Soc. Bras. Med. Trop. pmid:26108005
Gélisse P et al. [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. 2007 Rev. Neurol. (Paris) pmid:18033049
Estrada-Gómez RA et al. Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico. 2007 Mar-Apr Rev. Invest. Clin. pmid:17633798
Leal YA et al. A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy. 2008 Nov-Dec Rev. Invest. Clin. pmid:19378833
Gutiérrez-Castrellón P et al. Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. 2012 Mar-Apr Rev. Invest. Clin. pmid:22991774
Ramzy I et al. GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS. 2016 Rev. Inst. Med. Trop. Sao Paulo pmid:27982354
Picoli SU et al. Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients. 2014 May-Jun Rev. Inst. Med. Trop. Sao Paulo pmid:24878996
Vianna JS et al. The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. 2018 Rev. Inst. Med. Trop. Sao Paulo pmid:29972462
Colomina Rodríguez J et al. [Impact of Integrated Model for Rational Use of Antibiotics in a health area (project MIURA)]. Rev. Esp. Salud Publica pmid:20661527
Roche B et al. Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. 1997 Rev Rhum Engl Ed pmid:9051864
Bronstein JA [National ranking exam. N63. What could fall at the exam?]. 2008 Rev Prat pmid:18506983
Lamouliatte H et al. [Treatment of Helicobacter pylori infection]. 2000 Rev Prat pmid:11019637
Melo-Cristino J et al. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004. Rev Port Pneumol pmid:16572254
Dautzenberg B [Treatment of atypical mycobacterium infections: current state and therapeutic perspectives]. 1992 Rev Pneumol Clin pmid:1296257
Flores-Gonzalez JC et al. [Etiology, clinical presentation and outcome of severe viral acute childhood encephalitis (ECOVE study)]. 2015 Rev Neurol pmid:26108903
Scheen AJ [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. 1998 Rev Med Liege pmid:9555183
Lutgen N et al. [Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege]. 2001 Rev Med Liege pmid:11256133
Guiot J et al. [Mycobacterium malmoense infection in an immunocompetent patient]. 2009 Jul-Aug Rev Med Liege pmid:19777918
Niang M et al. [Painful nodular lesions]. 1998 Rev Med Interne pmid:9793156
Cinquetti G et al. [Rare complications of Lemierre's syndrome: septic sternoclavicular joint arthritis and cavitating pneumonia]. 2009 Rev Med Interne pmid:19896753
Leclercq V et al. [Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine]. 2005 Rev Med Interne pmid:16023268
de Korwin JD [Helicobacter pylori infection and antimicrobial agents resistance]. 2004 Rev Med Interne pmid:14736561
Poiată A et al. [Meropenem activity against staphylococci]. 2005 Jan-Mar Rev Med Chir Soc Med Nat Iasi pmid:16607852
González C et al. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin]. 2001 Rev Med Chil pmid:11510204
Pavié G J et al. [Assessment of the management of community-acquired pneumonia in adults outpatients]. 2005 Rev Med Chil pmid:16446856
Sánchez H et al. [Compliance with guidelines for the management of community acquired pneumonia at primary health care centers]. 2009 Rev Med Chil pmid:20361133
Alvarez A et al. [Antimicrobial susceptibility of Helicobacter pylori strains isolated in Colombia]. 2009 Rev Med Chil pmid:20011937
Fariña N et al. [Antimicrobial susceptibility of H pylori strains obtained from Paraguayan patients]. 2007 Rev Med Chil pmid:17989858
García-Agudo L et al. [Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test]. 2009 Rev Med Chil pmid:19802419
Vallejos C et al. [Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients]. 2007 Rev Med Chil pmid:17505573
Job V et al. [Medical-surgical treatment of pulmonary infection with Mycobacterium malmoense]. 2004 Rev Mal Respir pmid:15622347
Dautzenberg B et al. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection]. 1994 Rev Mal Respir pmid:8041990
Huet D et al. [Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. 2017 Rev Mal Respir pmid:27639948
Camara B et al. [Infection due to Mycobacterium malmoense in an immunocompetent patient]. 2008 Rev Mal Respir pmid:19106910
Schubel K et al. [Pleuropneumonia due to Mycobacterium chelonae]. 2011 Rev Mal Respir pmid:21482339
Dixmier A et al. [Pulmonary infections with Mycobacterium xenopi in patients without HIV infection]. 2007 Rev Mal Respir pmid:17417167
Frija-Masson J et al. [Non-tuberculous mycobacterial infection of a totally implanted perfusion device]. 2015 Rev Mal Respir pmid:25480387
Payen MC et al. [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. 1997 Rev Mal Respir pmid:9496599
Ramon PM et al. [Uveitis, arthralgia and pseudo-jaundice in a HIV seronegative patient due to rifabutin]. 1998 Rev Mal Respir pmid:9608993
Gomez-Abreo D et al. [Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. 2012 Rev Mal Respir pmid:22440310
[Zeclar, a new antibiotic (clarithromycin 250 mg from Abbott laboratories]. 1994 Rev Infirm pmid:7652424
Silva FM et al. Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in Brazilian patients with peptic ulcer. 2001 Jan-Feb Rev Hosp Clin Fac Med Sao Paulo pmid:11378678
Pinto LA et al. Effect of clarithromycin on the cell profile of bronchoalveolar lavage fluid in mice with neutrophil-predominant lung disease. 2004 Rev Hosp Clin Fac Med Sao Paulo pmid:15286828
Souza R et al. Diffuse panbronchiolitis: an underdiagnosed disease? Study of 4 cases in Brazil. 2002 Jul-Aug Rev Hosp Clin Fac Med Sao Paulo pmid:12244337
Ramírez Ramos A [Treatment of Helicobacter pylori infection: current status]. 1995 Rev Gastroenterol Peru pmid:8520021
Rodríguez W et al. [Omeprazole, amoxicillin and clarithromycin in the treatment of helicobacterpylori, in 7 and 10-day regimens]. 2003 Jul-Sep Rev Gastroenterol Peru pmid:14532918
Velasco Benítez CA and Amorocho Pérez RD [Treatment of gastritis-associated Helicobacter pylori infection in children]. 2002 Apr-Jun Rev Gastroenterol Peru pmid:12098744
Guarner J and Mohar A [The association between Helicobacter pylori and gastric neoplasia. Epidemiologic evidence]. 2000 Oct-Dec Rev Gastroenterol Mex pmid:11464618
Ladrón de Guevara L et al. [Evaluation of the symptomatology and quality of life in functional dyspepsia before and after Helicobacter pylori eradication treatment]. 2004 Oct-Dec Rev Gastroenterol Mex pmid:15765971
Dehesa M et al. [Comparison of 2 schedules based on pantoprazole for eradication of Helicobacter pylori in patients with active duodenal ulcer]. 1998 Apr-Jun Rev Gastroenterol Mex pmid:10068730